Advertisement
In addition, the company feels the current share price of their stock isnot a true reflection of the value of the company's current business state.
Advertisement
The company released the following statement: "We're pleased to announcethe company has begun a program in the U.K. to monitor patients remotelymanaging their diabetes and blood pressure. This program will be managed byDr. Kevin Curran who states that the main focus of the program is to show howtechnology can assist in monitoring patients from their home in modern lifewith the main emphasis being to reduce costs for the healthcare systemsworldwide and improve the care delivered to patients. Our program is designedto assist doctors in helping patients to control diabetes through the up-to-the-minute online reports of their insulin levels.
The company further announced that the current share price is notindicative of the true value and potential of the company. This program, alongwith the others that are set to begin soon, have the potential to bring inexcess of $100 million dollars for the length of these contracts. This makesno sense to us how the share price declines while the business is poised to bea force in the very near future. Management's confidence remains high andfeels the future of this company remains bright."
To find out more about Ulster University, please visit their site athttp://www.ulster.ac.uk
For any healthcare agency or physician group that would like to find outmore about how XTend can assist in your management of diabetic patients,please visit the company website at http://www.xtendmedical.com or email us [email protected]
About XTend Medical: XTend Medical Corporation markets and sellshealthcare and wellness products to hospitals, managed care companies, nursinghomes, physician groups and individual patients. XTend has developed acomplete Remote Diabetic Patient Monitoring System that is currently beingused by physicians and other healthcare agencies throughout the U.S. Throughtheir alliances, XTend offers pharmacy services, diabetic supplies, andtelemedicine products that increase patient care yet reduce costs associatedwith servicing those patients. For more information, please visit theirwebsite at http://www.xtendmedical.com
Safe Harbor
This press release contains or may contain forward-looking statements suchas statements regarding the Company's growth and profitability, growthstrategy, liquidity and access to public markets, operating expense reduction,and trends in the industry in which the Company operates. The forward-lookingstatements contained in this press release are also subject to other risks anduncertainties, including those more fully described in the Company's filingswith the Securities and Exchange Commission. The Company assumes no obligationto update these forward-looking statements to reflect actual results, changesin risks, uncertainties or assumptions underlying or affecting suchstatements, or for prospective events that may have a retroactive effect.Contact: Company Contact: FutureTechIR for XTend Medical Corporation Investor Relations (817) 812-2105
SOURCE XTend Medical Corporation
